TICKVALE
>⌘K
Nasdaq · CIK 0001792044 · PHARMACEUTICAL PREPARATIONS

VIATRIS INC.

VTRS chart by TradingView
P/E P/B 1.3xP/SALES 1.3xEV/EBITDA 11.4xFCF YIELD 10.58%

PRICE HISTORY

LIVE · NASDAQ
VTRS chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$14.3B
EBITDA
$0.1B
FREE CASH FLOW
$1.9B
EPS
GROSS MARGIN
35.06%
ROIC
-12.64%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 28 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

-35%
LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
6.1x413.0x

P / SALES (TTM)

1.3x
-57%
LATEST · Q2 FY26
1.3xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
0.6x3.1x

P / BOOK

1.3x
+89%
LATEST · Q2 FY26
1.3xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
0.4x1.3x

EV / EBITDA (TTM)

11.4x
-32%
LATEST · Q2 FY26
11.4xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
5.4x204.1x

EV / REVENUE (TTM)

2.1x
-71%
LATEST · Q2 FY26
2.1xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
1.6x7.4x

FCF YIELD (TTM)

10.58%
+0.4pp
LATEST · Q2 FY26
10.58%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
10.20%27.78%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$3.8B
+$3.8B
LATEST · Q2 FY26
3.8BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

EBITDA (DERIVED)

$0.6B
-4%
LATEST · Q2 FY26
0.6BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

NET INCOME

$-0.1B
$0.1B
LATEST · Q2 FY26
-0.1BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

EPS (DILUTED)

$-0.10
$0.10
LATEST · Q2 FY26
-0.10Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

REVENUE GROWTH YOY

4.88%
-69.9pp
LATEST · Q2 FY26
4.88%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
-53.45%74.78%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

8.76%
-0.7pp
LATEST · Q2 FY26
8.76%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
0.91%25.62%

RETURN ON CAPITAL

-1.54%
-1.7pp
LATEST · Q2 FY26
-1.54%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
-13.03%5.32%

RETURN ON EQUITY (TTM)

-2.88%
-3.1pp
LATEST · Q2 FY26
-2.88%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
-24.26%9.86%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN38.77%
OPERATING MARGIN0.17%
NET MARGIN-3.16%
FCF MARGIN8.76%
56.5415.63-25.29-66.20-107.11GROSSOPERNETFCFQ1 FY19Q2 FY20Q1 FY21Q4 FY21Q3 FY22Q2 FY23Q1 FY24Q4 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$0.3B
+$0.4B
LATEST · Q2 FY26
0.3BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

STOCK-BASED COMP

$0.0B
+99%
LATEST · Q2 FY26
0.0BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.1B
+22%
LATEST · Q2 FY26
0.1BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

SHARES OUTSTANDING

1.16B
+125%
LATEST · Q2 FY26
1.16BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

DIVIDEND / SHARE

+9%
LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$0.9B
+55%
LATEST · Q2 FY26
0.9BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

TOTAL DEBT

$13.4B
+17%
LATEST · Q2 FY26
13.4BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

DEBT / EBITDA (TTM)

4.9x
-60%
LATEST · Q2 FY26
4.9xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
3.6x106.6x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 89.83%INSIDERS 0.32%OTHER / RETAIL 9.86%1,360 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.7.24%84.4M$1.39B-2.8%
Davis Selected Advisers6.72%78.2M$1.29B+0.0%
Vanguard Capital Management LLC6.42%74.7M$1.23BNEW
Price (T.Rowe) Associates Inc5.66%65.9M$1.08B-16.7%
Vanguard Portfolio Management LLC4.63%53.9M$885.8MNEW
State Street Corporation4.49%52.2M$858.2M-5.6%
Dimensional Fund Advisors LP3.29%38.3M$629.4M-4.3%
Rubric Capital Management LP2.88%33.5M$550.4M+31.4%
Geode Capital Management, LLC2.73%31.8M$523.2M+2.4%
Invesco Ltd.1.89%22.0M$360.9M-5.8%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.